Clinical Overview

“Left Front Bundle Branch Block” (LFBBB) is this dataset’s label for what standard ECG teaching calls left bundle branch block (LBBB): a complete block of conduction down the entire left bundle branch, not a fascicular (hemiblock) finding, despite a name that reads as though it named the left anterior fascicle. Several independent lines of evidence agree on this. The SNOMED CT code this dataset assigns to LFBBB resolves to the standard complete-LBBB concept, not to the distinct code used for left anterior fascicular block. The dataset’s own label inventory already carries dedicated entries for both true fascicular blocks — left anterior fascicular block (LAnFB) and left posterior fascicular block (LPFB) — as well as a separate incomplete left bundle branch block label (ILBBB), so LFBBB is the remaining, complete-grade left-sided entry those other labels do not cover. And within this dataset, LFBBB never co-occurs on the same tracing as complete right bundle branch block (CRBBB) or as LAnFB — consistent with LFBBB being a distinct, complete block of the whole left bundle rather than either a right-sided block or a same-side fascicular delay, since two complete bundle branch blocks cannot coexist on one 12-lead recording. This page is scoped to true, complete LBBB; the true fascicular finding is covered on this dataset’s separate left anterior fascicular block page (StatPearls, Left Bundle Branch Block, 2024; LITFL, Left Bundle Branch Block, 2024).

Mechanistically, the left bundle branch normally activates the interventricular septum first, left to right, and then the bulk of the left ventricle in step with the right ventricle’s own, separate right bundle branch. When the left bundle branch is completely blocked, the left ventricle receives no impulse through the specialized conduction system at all; it is instead activated late, indirectly, by depolarization spreading cell-to-cell across the septum from the intact right bundle branch. This reverses the normal left-to-right septal activation sequence, which erases the small septal q wave normally seen in leads I, V5, and V6, and produces one broad, often notched or slurred monophasic R wave through the left ventricle’s usual activation window in those same lateral leads, paired with a dominant S wave in V1 where the delayed leftward forces point away from the recording electrode. Because the entire left ventricle is depolarizing later and by a slower, non-specialized route, the QRS widens to 120 ms or more — the same 120 ms threshold used by the AHA/ACCF/HRS 2009 intraventricular conduction disturbance standardization statement and confirmed unchanged by current sources (Surawicz et al., Circulation, 2009; StatPearls, 2024; Merck Manual Professional Edition, 2024; LITFL, 2024). Repolarization follows the same reversed sequence, producing secondary ST-T changes that point opposite the dominant QRS direction in each lead — “appropriately discordant” rather than a primary ischemic finding on its own.

Clinical significance depends on more than the label alone. LFBBB/LBBB is uncommon in the general population — roughly 0.06% to 0.1% — but becomes markedly more frequent with age, reaching 1% to 5% of people over 70 and 6% to 7% of people over 80, and affects men at roughly twice the rate of women (StatPearls, 2024). Unlike an isolated right bundle branch block, LBBB rarely occurs without some identifiable underlying structural or electrical heart disease, and it is present in roughly a third of patients with heart failure (StatPearls, 2024; Merck Manual Professional Edition, 2024). A 2025 cohort study of 4,541 adults 65 and older with normal baseline ejection fraction and no heart failure history found that those with LBBB had a nearly 5-fold higher risk of developing incident heart failure over follow-up (adjusted hazard ratio 4.98, 95% CI 2.18-11.39) and about 4.7 times the odds of a clinically meaningful drop in ejection fraction at 5 years (adjusted odds ratio 4.73, 95% CI 1.70-13.70), even though every participant started with a structurally normal heart (Thein, Dixit, Soliman et al., JAMA Network Open, 2025). Broader mortality data point the same direction: LBBB is associated with roughly 2.9 times the risk of cardiovascular mortality and 1.4 times the risk of all-cause mortality compared with people without it (StatPearls, 2024). [CLINICAL REVIEW NEEDED: these two mortality multipliers are stated by StatPearls without a named source cohort, so the population and confidence intervals behind them could not be independently confirmed this run.] Once LBBB accompanies a reduced ejection fraction and a sufficiently wide QRS, it becomes a Class I indication for cardiac resynchronization therapy or left bundle branch area pacing under current guidance (LVEF 35% or less, QRS 150 ms or more, NYHA class II-IV symptoms on optimized medical therapy) (Chung et al., 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing, Heart Rhythm, 2023). New LBBB accompanying chest pain also changes how the ECG is read for possible myocardial infarction: because the block’s own secondary repolarization changes can mimic or mask ischemic ST-T changes, acute coronary syndrome in that setting is assessed with the Sgarbossa criteria (and the more sensitive Smith-modified version, which replaces the original’s fixed 5 mm discordant-ST-elevation cutoff with a cutoff proportional to the preceding S wave’s depth) rather than by treating a new block as an automatic STEMI-equivalent (LITFL, Sgarbossa Criteria, 2025; LITFL, Left Bundle Branch Block, 2024).

LFBBB/LBBB itself produces no symptoms in most people — it is a conduction finding, not a rhythm disturbance, and many patients only learn they have it from a routine ECG (Cleveland Clinic, 2022; Merck Manual Professional Edition, 2024). When symptoms are present, they typically come from the underlying cause or from LBBB’s own effect on ventricular mechanics: interventricular mechanical dyssynchrony from the delayed, indirect left-ventricular activation can reduce pumping efficiency and contribute to heart failure symptoms such as dyspnea and fatigue over time, and less commonly LBBB is associated with bradycardia, presyncope, or syncope (Merck Manual Professional Edition, 2024; Cleveland Clinic, 2022).

Recognized causes and risk factors include coronary artery disease (particularly prior anterior myocardial infarction, which can indicate substantial myocardial damage), hypertensive heart disease, aortic valve disease, dilated and other cardiomyopathies, myocarditis, and age-related fibrodegenerative disease of the conduction system (Lenègre’s or Lev’s disease) (StatPearls, 2024; Merck Manual Professional Edition, 2024; Cleveland Clinic, 2022). Transcatheter aortic valve replacement (TAVR) is a well-documented iatrogenic cause, producing new LBBB in roughly 30% to 50% of patients (StatPearls, 2024). Reversible metabolic and drug causes — hyperkalemia and digoxin toxicity among them — are also recognized and should be considered, particularly when the block is new and unexplained (LITFL, 2024; StatPearls, 2024). LBBB can also occur with no identifiable structural cause in an otherwise healthy person, though this is less common than with right bundle branch block (Cleveland Clinic, 2022).

Interpretation Guide

Key Features:

• Rate: not a defining feature — LBBB is a conduction finding superimposed on whatever rate accompanies the underlying rhythm
• Rhythm: not a defining feature — LBBB describes how the impulse reaches the ventricles, not where the rhythm originates or its regularity
• P waves: within normal limits; the block sits below the AV node, so atrial depolarization is unaffected
• PR interval: within normal limits (0.12-0.20 s) unless a separate, coexisting AV conduction disturbance is present
• QRS complex: the defining feature — duration 120 ms or more, with a broad, often notched or slurred monophasic R wave and no septal q wave in leads I, aVL, V5, and V6, an R wave peak time greater than 60 ms in V5-V6, and a dominant, often QS or rS, complex in V1-V2. A stricter research-grade threshold (QRS ≥140 ms in men, ≥130 ms in women) has also been proposed and is used mainly to select patients for cardiac resynchronization therapy studies rather than for routine diagnosis (StatPearls, 2024)
• ST segment: appropriately discordant — ST depression in leads with a tall, dominant R wave (the lateral leads) and ST elevation in leads with a deep S wave (V1-V3), reflecting the reversed repolarization sequence rather than primary ischemia; any ST change that is concordant with (in the same direction as) the QRS instead is concerning for ischemia and should be evaluated with the Sgarbossa criteria
• T waves: appropriately discordant T wave inversion in the lateral leads, following the same reversed sequence as the ST changes above; confirmatory rather than independently diagnostic
• QT interval: not independently diagnostic — widening the QRS mechanically lengthens the measured QT, so an apparently prolonged QT on a strip with this block may simply reflect the QRS width already recorded
• Other findings: the frontal-plane axis commonly shifts leftward with LBBB; a marked leftward shift here reflects the block itself rather than necessarily indicating a separate, coexisting fascicular block, so leftward axis alone should not be read as evidence of bifascicular disease in the presence of a QRS that already meets LBBB’s own morphology criteria

Key Leads

• Leads I, aVL, V5-V6 — the key discriminating leads: a broad, notched or slurred monophasic R wave with no septal q wave and an R wave peak time over 60 ms confirms delayed, indirect left-ventricular activation
• Lead V1 — shows the mirror-image finding: a dominant S wave (QS or rS pattern), since the delayed leftward forces point away from this lead
• Whichever lead shows the widest QRS complex — used to confirm the 120 ms complete-block threshold is actually crossed, since apparent width can vary by lead
• No single lead is optional — the diagnosis rests on the lateral-lead monophasic R wave and the V1 dominant-S-wave pattern occurring together, not either alone

Differential Diagnosis

• Left Anterior Fascicular Block (LAnFB) — the true fascicular block this dataset’s LFBBB label is easy to confuse with on name alone, and the block LFBBB never co-occurs with in this dataset’s own records. Distinguishing clue: LAnFB keeps the QRS normal or only slightly prolonged (under 120 ms) with a discrete qR pattern in I/aVL and rS pattern in II/III/aVF, instead of LBBB’s broad, notched monophasic R wave and 120 ms-or-greater QRS.
• Complete Right Bundle Branch Block (CRBBB) — the mirror-image complete block, and one this dataset’s LFBBB label never shares a tracing with, since two complete bundle branch blocks cannot both be read on one 12-lead ECG. Distinguishing clue: CRBBB shows an RSR’ (“M-shaped”) pattern in V1-V2 with a wide, slurred terminal S wave in the lateral leads — the opposite morphology from LBBB’s dominant S in V1 and monophasic R in the lateral leads.
• Intraventricular Block (IVB) — this dataset’s label for a non-specific, widened QRS that does not meet either bundle branch block’s defined morphology. Distinguishing clue: IVB is a diagnosis of exclusion; if the lateral-lead monophasic R wave and V1 dominant S wave criteria above are met, the strip belongs on this page instead, not on IVB’s.
• Left Ventricle Hypertrophy (LVH) — LBBB’s own tall lateral R waves and secondary ST depression/T wave inversion can reproduce both halves of the LVH voltage-and-strain picture without hypertrophy being present. Distinguishing clue: measure the QRS duration and check for LBBB’s specific monophasic-R/no-septal-q morphology before applying any LVH voltage criteria — a QRS at or above 120 ms with that morphology points to LBBB, not LVH, as the explanation for lateral-lead voltage and strain.
• Axis Left Shift (ALS) — LBBB commonly shifts the frontal-plane axis leftward, which can be mistaken for an isolated axis finding. Distinguishing clue: a QRS at or above 120 ms with LBBB’s own defining lateral-lead and V1 morphology identifies the axis shift as a consequence of LBBB rather than an unrelated or isolated finding.

Treatment Brief

LFBBB/LBBB is a descriptive ECG finding, not a rhythm to treat directly — the response depends on whether it is new, what accompanies it, and the patient’s overall cardiac status.

• Compare against a prior ECG whenever one is available; a new left bundle branch block deserves more attention than a longstanding, stable one, since it more often signals evolving structural heart disease than an incidental finding.
• If a new or presumed-new LBBB accompanies chest pain or another presentation concerning for acute coronary syndrome, notify the provider promptly — this block’s own secondary ST-T changes can mask or mimic ischemia, so acute MI in this setting is assessed with the Sgarbossa criteria rather than standard ST-elevation criteria.
• For a patient with known reduced ejection fraction or heart failure, flag a new or longstanding LBBB explicitly; it is directly relevant to that patient’s candidacy for cardiac resynchronization therapy or conduction-system pacing, a decision for the care team rather than something to act on at the bedside.
• Isolated, asymptomatic LBBB in a patient without known heart disease does not require acute intervention, but given its association with later heart failure and structural disease, it is reasonable to flag for outpatient follow-up rather than dismiss as incidental.
• Check the patient’s potassium level and medication list (digoxin in particular) if a reversible metabolic or drug cause is plausible for a new, otherwise unexplained block.
• Confirm lead placement and repeat the tracing if the finding is new or unexpected.